☆ 4.6 Review

Current Trends in Mucosal Melanomas: An Overview

CANCERS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive Review

Alice Indini et al.

Summary: Mucosal melanoma is a rare and aggressive subtype of melanoma that has shown poor response to novel treatment approaches. Recent molecular studies have revealed potential therapeutic targets and the potential benefits of immunotherapy in this disease. However, further research is needed to confirm these findings in different studies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Genetics & Heredity

Mutational Characteristics of Primary Mucosal Melanoma: A Systematic Review

Olivia Beaudoux et al.

Summary: This article systematically reviews molecular studies of primary mucosal melanomas (PMMs) to elucidate their pathogenesis and potential therapeutic targets. The study identified significantly mutated genes, including BRAF, NRAS, and KIT, as well as others that may be associated with future targeted therapies.

MOLECULAR DIAGNOSIS & THERAPY (2022)

添加到收藏夹

Article Medicine, General & Internal

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

Hussein A. Tawbi et al.

Summary: LAG-3 and PD-1 are two distinct inhibitory immune checkpoints that contribute to T-cell exhaustion. The combination of relatlimab and nivolumab has been shown to be safe and effective in previously treated melanoma patients, and this study aimed to evaluate its safety and activity in previously untreated melanoma patients. The results demonstrated that the combination therapy provided a greater benefit in terms of progression-free survival compared to nivolumab alone, without any new safety signals.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Oncology

Vulvar Melanoma in association with germline MITF p.E318K variant

Diane R. Koeller et al.

Summary: This study reports the presence of a germline MITF p.E318K pathogenic variant in a woman with vulvar melanoma and a family history of cutaneous melanoma. This finding highlights the potential role of MITF p.E318K in risk assessment and clinical management of patients with vulvar melanoma.

CANCER GENETICS (2022)

添加到收藏夹

Article Oncology

Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis

Siming Li et al.

Summary: This study reported the updated overall survival, duration of response, and biomarker analysis results of the combination therapy of axitinib and toripalimab in patients with metastatic mucosal melanoma. The results showed that this combination therapy had antitumor activity and long-term survival benefit in patients with advanced MM. A certain gene expression profile was found to be valuable in predicting treatment outcomes, but further validation is needed.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

添加到收藏夹

Review Oncology

Evolving Treatment Approaches to Mucosal Melanoma

Shuai Zhang et al.

Summary: Mucosal melanoma differs from cutaneous melanoma in terms of epidemiology, clinical features, and molecular landscape, and has poorer response to systemic therapy. However, recent advancements in targeted therapy options and combination treatments have provided promising prospects for improving clinical outcomes.

CURRENT ONCOLOGY REPORTS (2022)

添加到收藏夹

Article Oncology

Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study

F. Dimitriou et al.

Summary: Mucosal melanoma (MM) is a rare subtype of melanoma with poor prognosis. The efficacy of immune checkpoint inhibitors (ICIs) in treating MM appears to be consistent across different ethnicities and primary sites. Combination therapy with anti-PD-1 and ipilimumab shows a slightly higher response rate in naso-oral primaries.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Toripalimab (anti-PD-1) versus high-dose interferon-a2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial

B. Lian et al.

Summary: This study compared the adjuvant therapy of toripalimab and high-dose interferon-a2b in resected mucosal melanoma patients. The results showed similar relapse-free survival (RFS) in both groups, but toripalimab had a more favorable safety profile. Therefore, toripalimab may be a better treatment option for these patients.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Metabolic heterogeneity protects metastatic mucosal melanomas cells from ferroptosis

Weifan Lin et al.

Summary: This study investigated the association between cancer heterogeneity and metastasis in melanoma. The COMM-SUS cells, which exhibited higher metastatic capacities, showed metabolic reprogramming and resistance to cell death induced by oxidative stress. Inhibiting lactate uptake and impairing PPP activation decreased the metastatic potential of the COMM-SUS cells.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2022)

添加到收藏夹

Article Genetics & Heredity

Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes

Meng Wang et al.

Summary: This study conducted a meta-analysis of sequencing data from acral and mucosal melanoma samples and identified important genetic mutations and gene amplifications, providing important clues for understanding the pathogenesis and therapeutic targets of these difficult-to-treat cancers.

GENOME MEDICINE (2022)

添加到收藏夹

Review Pathology

Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature

Malgorzata Chlopek et al.

Summary: This study examined the mutational profile of sinonasal mucosal melanoma, revealing the presence of NRAS and other key components and regulators of the Ras-MAPK signaling pathway in the majority of cases.

MODERN PATHOLOGY (2022)

添加到收藏夹

Article Immunology

mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model

Chutamath Sittplangkoon et al.

Summary: This study found that an unmodified mRNA vaccine can induce IFN-I production and the maturation of dendritic cells, leading to significant inhibition of tumor growth and prolonged survival. In addition, the unmodified mRNA vaccine can increase the frequency of CD40+ DCs and polyfunctional OVA-specific CD8+ T cells in tumors, resulting in a robust anti-tumor effect.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Oncology

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma

Joel Ho et al.

Summary: This study aimed to investigate the safety and efficacy of neoadjuvant checkpoint inhibition (CPI) in patients with resectable mucosal melanoma (MM). The results showed that neoadjuvant CPI for resectable MM is a feasible approach with signs of efficacy and an acceptable safety profile.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Development of therapeutic vaccines for the treatment of diseases

Yaomei Tian et al.

Summary: Vaccines are effective interventions in combating newly emerging and re-emerging diseases. Prophylactic vaccines have excellent effectiveness in preventing viral infection, while therapeutic vaccines aim to reshape host immunity to eradicate the disease. Various technological strategies have been implemented in the development of therapeutic vaccines.

MOLECULAR BIOMEDICINE (2022)

添加到收藏夹

Editorial Material Oncology

Incorporating VEGF Blockade Into a Shifting Treatment Paradigm for Mucosal Melanoma

Alexander N. Shoushtari

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma

Xieqiao Yan et al.

Summary: The study demonstrates that adding bevacizumab to the treatment of carboplatin plus paclitaxel significantly improves progression-free survival and overall survival in patients with metastatic mucosal melanoma.

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma

Natasa Broit et al.

Summary: The study provides a comprehensive analysis of genomic aberrations in mucosal melanoma, identifying key driver genes and pathways involved in tumorigenesis. Statistical analysis revealed common genetic alterations and signaling networks that shed light on potential therapeutic targets in this rare subtype of melanoma.

MOLECULAR CANCER RESEARCH (2021)

添加到收藏夹

Article Oncology

Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma

Yousef Zakharia et al.

Summary: The combination therapy of indoximod and pembrolizumab showed promising anti-tumor efficacy in advanced melanoma patients, especially in PD-L1 positive patients. The treatment was well tolerated with expected side effects similar to pembrolizumab alone.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

添加到收藏夹

Article Cell Biology

Prognostic Roles of BRAF, KIT, NRAS, IGF2R and SF3B1 Mutations in Mucosal Melanomas

Joanna P. Wroblewska et al.

Summary: The NRAS mutation is an independent predictor of worse survival in mucosal melanomas, while the significance of other related mutations remains unclear.

CELLS (2021)

添加到收藏夹

Review Oncology

The mutational landscape of mucosal melanoma

Kelsey W. Nassar et al.

SEMINARS IN CANCER BIOLOGY (2020)

添加到收藏夹

Review Medical Laboratory Technology

The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway

David E. Elder et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Significance of 5-S-Cysteinyldopa as a Marker for Melanoma

Kazumasa Wakamatsu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Oncology

Overall survival and biomarker analysis of a phase Ib combination study of toripalimab, a humanized IgG4 mAb against programmed death-1 (PD-1) with axitinib in patients with metastatic mucosal melanoma.

Xinan Sheng et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Primary malignant melanoma of the esophagus with multiple lymph node metastases A case report and literature review

Kenichi Iwasaki et al.

MEDICINE (2020)

添加到收藏夹

Article Oncology

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma

Nicholas D. Klemen et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

添加到收藏夹

Review Medicine, General & Internal

Molecular Profiling of Advanced Malignancies: A Community Oncology Network Experience and Review of Literature

Pritam Tayshetye et al.

FRONTIERS IN MEDICINE (2020)

添加到收藏夹

Review Oncology

BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients

Umberto Malapelle et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)

添加到收藏夹

Review Medicine, General & Internal

Primary Melanoma of the Lung: A Systematic Review

Panagiotis Paliogiannis et al.

MEDICINA-LITHUANIA (2020)

添加到收藏夹

Review Oncology

Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review

Jiarui Li et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations

Rong Zhou et al.

CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Oncology

miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy

Huan Tang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Oncology

Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma

Antoine Moya-Plana et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy

Longwen Xu et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets

Felicity Newel et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Oncology

Variable indoleamine 2,3-dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy

Natsuko Iga et al.

CANCER SCIENCE (2019)

添加到收藏夹

Article Oncology

Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G4 Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial

Xinan Sheng et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation

Lei Miao et al.

NATURE BIOTECHNOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas

Maria Colombino et al.

JOURNAL OF CLINICAL MEDICINE (2019)

添加到收藏夹

Review Oncology

Atypical BRAF and NRAS Mutations in Mucosal Melanoma

Nicolas Dumaz et al.

CANCERS (2019)

添加到收藏夹

Article Medicine, Research & Experimental

MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways

Meng Ma et al.

THERANOSTICS (2019)

添加到收藏夹

Article Oncology

Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients

ChuanLiang Cui et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006

Omid Hamid et al.

BRITISH JOURNAL OF CANCER (2018)

添加到收藏夹

Review Oncology

Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches

Giuseppe Palmieri et al.

CURRENT ONCOLOGY REPORTS (2018)

添加到收藏夹

Article Oncology

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

Frank Stephen Hodi et al.

LANCET ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma

Claire Mignard et al.

JOURNAL OF ONCOLOGY (2018)

添加到收藏夹

Review Oncology

Combatting mucosal melanoma: recent advances and future perspectives

Helen Tyrrell et al.

MELANOMA MANAGEMENT (2018)

添加到收藏夹

Article Oncology

The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients

B. Lian et al.

ANNALS OF ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma

Markus V. Heppt et al.

EUROPEAN JOURNAL OF CANCER (2017)

添加到收藏夹

Article Oncology

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

Sandra P. D'Angelo et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Clinics, prognosis and new therapeutic options in patients with mucosal melanoma A retrospective analysis of 75 patients

Tim Schaefer et al.

MEDICINE (2017)

添加到收藏夹

Article Oncology

Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma

Jennifer D. Hintzsche et al.

MELANOMA RESEARCH (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Whole-genome landscapes of major melanoma subtypes

Nicholas K. Hayward et al.

NATURE (2017)

添加到收藏夹

Article Oncology

BRAF inhibitors: efficacious and tolerable in BRAF-mutant acral and mucosal melanoma

X. Bai et al.

NEOPLASMA (2017)

添加到收藏夹

Article Oncology

Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial

J. Guo et al.

ANNALS OF ONCOLOGY (2017)

添加到收藏夹

Review Oncology

Mucosal melanoma of the head and neck

Paolo Antonio Ascierto et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)

添加到收藏夹

Article Oncology

The Efficacy of Anti-PD-1 Agents in Acral and Mucosal Melanoma

Alexander N. Shoushtari et al.

CANCER (2016)

添加到收藏夹

Review Dermatology

RASopathy Gene Mutations in Melanoma

Ruth Halaban et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)

添加到收藏夹

Article Dermatology

Epidemiology of genitourinary melanoma in the United States: 1992 through 2012

Ritva Vyas et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)

添加到收藏夹

Article Oncology

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis

Deborah Kuk et al.

ONCOLOGIST (2016)

添加到收藏夹

Article Oncology

Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition

Richard D. Carvajal et al.

CLINICAL CANCER RESEARCH (2015)

添加到收藏夹

Article Immunology

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors

Thibault Voron et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

添加到收藏夹

Article Medicine, General & Internal

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

Georgina V. Long et al.

LANCET (2015)

添加到收藏夹

Article Oncology

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

Antoni Ribas et al.

LANCET ONCOLOGY (2015)

添加到收藏夹

Article Oncology

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Jeffrey S. Weber et al.

LANCET ONCOLOGY (2015)

添加到收藏夹

Article Medicine, General & Internal

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Medicine, General & Internal

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Caroline Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Medicine, General & Internal

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

J. Larkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Oncology

Melanoma of the Vulva and Vagina: Principles of Staging and Their Relevance to Management Based on a Clinicopathologic Analysis of 85 Cases

Susan Seifried et al.

ANNALS OF SURGICAL ONCOLOGY (2015)

添加到收藏夹

Article Oncology

Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence

Moriah H. Nissan et al.

CANCER RESEARCH (2014)

添加到收藏夹

Article Oncology

Efficacy and safety of ipilimumab 3 mg/kg in patients with pretreated, metastatic, mucosal melanoma

Michele Del Vecchio et al.

EUROPEAN JOURNAL OF CANCER (2014)

添加到收藏夹

Article Medicine, General & Internal

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Caroline Robert et al.

LANCET (2014)

添加到收藏夹

Article Medicine, General & Internal

Ipilimumab in pretreated patients with unresectable or metastatic cutaneous, uveal and mucosal melanoma

Marliese Alexander et al.

MEDICAL JOURNAL OF AUSTRALIA (2014)

添加到收藏夹

Article Dermatology

Unexpected Distribution of cKIT and BRAF Mutations among Southern Italian Patients with Sinonasal Melanoma

Maria Colombino et al.

DERMATOLOGY (2013)

添加到收藏夹

Article Oncology

Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin

F. Stephen Hodi et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

添加到收藏夹

Article Oncology

Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma

Simon J. Furney et al.

JOURNAL OF PATHOLOGY (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Signatures of mutational processes in human cancer

Ludmil B. Alexandrov et al.

NATURE (2013)

添加到收藏夹

Article Oncology

Ipilimumab for Patients With Advanced Mucosal Melanoma

Michael A. Postow et al.

ONCOLOGIST (2013)

添加到收藏夹

Article Oncology

Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations

Nicola L. Schoenewolf et al.

EUROPEAN JOURNAL OF CANCER (2012)

添加到收藏夹

Article Oncology

Nilotinib in patients with metastatic melanoma harboring KIT gene aberration

Jin Hyun Cho et al.

INVESTIGATIONAL NEW DRUGS (2012)

添加到收藏夹

Review Oncology

Mucosal Melanoma: A Clinically and Biologically Unique Disease Entity

Richard D. Carvajal et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)

添加到收藏夹

Article Medicine, General & Internal

Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer

Suzanne L. Topalian et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

添加到收藏夹

Article Oncology

Mucosal Melanoma: Pathogenesis, Clinical Behavior, and Management

Michael A. Postow et al.

CURRENT ONCOLOGY REPORTS (2012)

添加到收藏夹

Article Oncology

Noncutaneous Melanoma Have Distinct Features from Each Other and Cutaneous Melanoma

Faruk Tas et al.

ONCOLOGY (2011)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Treatment of Primary Melanoma of the Lung Monitored by 5-S-Cysteinyldopa Levels

Kei Shikuma et al.

ANNALS OF THORACIC SURGERY (2009)

添加到收藏夹

Article Otorhinolaryngology

Endoscopic Resection of Sinonasal Cancers With and Without Craniotomy Oncologic Results

Ehab Hanna et al.

ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2009)

添加到收藏夹

Article Oncology

KIT Gene Mutations and Copy Number in Melanoma Subtypes

Carol Beadling et al.

CLINICAL CANCER RESEARCH (2008)

添加到收藏夹

Review Oncology

What is the role of radiotherapy in the treatment of mucosal melanoma of the head and neck?

Marco Krengli et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)

添加到收藏夹

Review Dentistry, Oral Surgery & Medicine

Oral malignant melanoma: a review of the literature

Felice Femiano et al.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2008)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy

Benjamin F. Johnson et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2007)

添加到收藏夹

Article Oncology

Somatic activation of KIT in distinct subtypes of melanoma

John A. Curtin et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

添加到收藏夹

Article Medicine, Research & Experimental

Primary mucosal melanoma of head and neck: Prognostic value of clear margins

N Penel et al.

LARYNGOSCOPE (2006)

添加到收藏夹

Article Medicine, General & Internal

Distinct sets of genetic alterations in melanoma

JA Curtin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

添加到收藏夹

Article Oncology

Incidence of noncutaneous melanomas in the US

CC McLaughlin et al.

CANCER (2005)

添加到收藏夹

Article Dermatology

Overproduction of VEGF165 concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling

J Graells et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)

添加到收藏夹

Article Oncology

Determinants of BRAF mutations in primary melanomas

JL Maldonado et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)

添加到收藏夹

Article Biochemistry & Molecular Biology

Development of melanocyte precursors from the vertebrate neural crest

E Dupin et al.

ONCOGENE (2003)

添加到收藏夹

Article Pathology

Sinonasal tract and nasopharyngeal melanomas - A clinicopathologic study of 115 cases with a proposed staging system

LDR Thompson et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)

添加到收藏夹

Article Otorhinolaryngology

Primary mucosal malignant melanoma of the head and neck

SG Patel et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.